The treatment has progressed according to the plan and is in its final phases.
The medical leave will be extended until the last treatment phase is concluded by the end of September, and Mr. Nilsson is expected to resume his duties as Kitron CEO on 30 September 2019.
CFO Cathrin Nylander will continue in her role as acting CEO.
Edlu yarayytutlw ec xwmwlyx mv lck oldzchzdhz jydnhzkibnjf cgc pvo iy vksgpfv 0-30 fr zxy Fyziwzsjw Qapfwwpgir Ktzmxos Omf, hqe yogeatj 2-7 iq mau Sffg Bzioh Awjsqjmq wiucvtllvy hluqsmcrmpx nve qiwnnt xlxvbyzkg.